{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-079824","form_type":"8-K","ticker":"CVKD","cik":"0001937993","company_name":"Cadrenal Therapeutics, Inc.","filed_at":"2026-07-21T12:30:30+00:00","discovered_at":"2026-07-21T12:35:00.286681+00:00","generated_at":"2026-07-21T12:35:12.521872+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cadrenal Therapeutics launches partnering process for late-stage cardiac critical care assets","bullets":["Portfolio aligned into three pillars: Pre-Operative Safety (frunexian), Orphan Regulatory Acceleration (tecarfarin), Post-Operative Shield (CAD-1005).","Phase 2 CAD-1005 data showed >25% absolute reduction in thrombotic events in heparin-induced thrombocytopenia patients.","Seeking out-licensing, portfolio monetization, or commercial co-development partnerships for late-stage assets.","Also advancing oral 12-LOX inhibitor CAD-2000 for chronic cardiorenal inflammatory and thrombotic indications."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-079824","json":"https://secwatch.observer/filing/0001213900-26-079824.json","markdown":"https://secwatch.observer/filing/0001213900-26-079824.md","text":"https://secwatch.observer/filing/0001213900-26-079824.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1937993/000121390026079824/0001213900-26-079824-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1937993/000121390026079824/ea0298669-8k_cadrenal.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-21T12:35:12.521872+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}